Filters
Project
Testing of the Anti-Arrhythmic Effects of Potential Drugs From The Group of Ultra-short-Acting Blockers of Adrenergic Receptors (NR9126)
Antiarrhytmic agents from the beta blocker group have the lowest arrhytmogenic effect and are thus most requested in the clinical practice. The compounds that we are testing belong to the group of ultra-short acting beta adrenergic receptor blockers....
FR - Farmakologie a lékárnická chemie
- 2006 - 2008 •
- 1 165 tis. Kč •
- 1 165 tis. Kč •
- MZ
Řešení projektu: 1. 1. 2006 - 31. 12. 2008
Uznané náklady
Podpora ze státního rozpočtu (100%)
Poskytovatel: Ministerstvo zdravotnictví
- 1 - 1 out of 1